Citation Impact

Citing Papers

Partial Surgical Removal of Growth Hormone-Secreting Pituitary Tumors Enhances the Response to Somatostatin Analogs in Acromegaly
2006
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
2009 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Tilt-Pair Analysis of Images from a Range of Different Specimens in Single-Particle Electron Cryomicroscopy
2011 StandoutNobel
Benchmarking the stability of human detergent-solubilised voltage-gated sodium channels for structural studies using eel as a reference
2015 StandoutNobel
Phosphorylation of the human estrogen receptor on tyrosine 537 in vivo and by src family tyrosine kinases in vitro.
1995
Reversal of acromegalic cardiomyopathy in young but not in middle‐aged patients after 12 months of treatment with the depot long‐acting somatostatin analogue octreotide
2003
Acromegaly
2006 Standout
Myasthenia Gravis
2016 Standout
Rectal Cancer: Primary Staging and Assessment After Chemoradiotherapy
2011
Evaluation of a new DTPA-derivative chelator: Comparative biodistribution and imaging studies of 111In-labeled B3 monoclonal antibody in athymic mice bearing human epidermoid carcinoma xenografts
1993
Electrochemotherapy of cholangiocellular carcinoma at hepatic hilum: A feasibility study
2018
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Comparative biodistribution studies of DTPA-derivative bifunctional chelates for radiometal labeled monoclonal antibodies
1991
Gallium-67 Scintigraphy in the Management: Hodgkin's Disease and Non-Hodgkin's Lymphoma
1999
Imaging in the era of molecular oncology
2008 StandoutNature
Cancer, Inflammation, and Therapy: Effects on Cytochrome P450–Mediated Drug Metabolism and Implications for Novel Immunotherapeutic Agents
2014
Phaeochromocytoma
2005 Standout
Novel Treatment Approaches for Triple-Negative Breast Cancer
2010
Tumor immunoediting and immunosculpting pathways to cancer progression
2007
Is the Acromegalic Cardiomyopathy Reversible? Effect of 5-Year Normalization of Growth Hormone and Insulin-Like Growth Factor I Levels on Cardiac Performance*
2001
18F-FDG PET and PET/CT in the Evaluation of Cancer Treatment Response
2009
The Implication of Somatotroph Adenoma Phenotype to Somatostatin Analog Responsiveness in Acromegaly
2005
Overexpression of folate binding protein and mesothelin are associated with uterine serous carcinoma
2007
Predictors of Tumor Shrinkage after Primary Therapy with Somatostatin Analogs in Acromegaly: A Prospective Study in 99 Patients
2006
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
2013 Standout
Electronic detectors for electron microscopy
2011
Colorectal cancer
2013 Standout
Expression of mediated P-glycoprotein multidrug resistance related to Tc-99m MIBI scintimammography results
2000
Phosphorylation on Tyrosine ofin VitroSynthesized Human Estrogen Receptor Activates Its Hormone Binding
1989
Molecular mechanisms of the antiproliferative activity of somatostatin receptors (SSTRs) in neuroendocrine tumors
2007
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
Thermal ablation of tumours: biological mechanisms and advances in therapy
2014 Standout
Phosphorylation on tyrosine of oestradiol-17β receptor in uterus and interaction of oestradiol-17β and glucocorticoid receptors with antiphosphotyrosine antibodies
1987
Properties of a purified estradiol-dependent calf uterus tyrosine kinase
1993
DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals
2003
Graves' Ophthalmopathy
2010 Standout
Safety and feasibility of electrochemotherapy in patients with unresectable colorectal liver metastases: A pilot study
2017
Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results
2011 Standout
Opportunities in somatostatin research: biological, chemical and therapeutic aspects
2003
Oesophageal carcinoma
2013 Standout
Long-Acting Somatostatin Analog Therapy of Acromegaly: A Meta-Analysis
2005
Cabergoline addition to depot somatostatin analogues in resistant acromegalic patients: efficacy and lack of predictive value of prolactin status
2004
Twelve months of treatment with octreotide-LAR reduces joint thickness in acromegaly
2003
Robust enumeration of cell subsets from tissue expression profiles
2015 Standout
High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy
2020 Standout
Exploratory Study of 99mTc-EC20 Imaging for Identifying Patients with Folate Receptor–Positive Solid Tumors
2008
Population-specific expression analysis (PSEA) reveals molecular changes in diseased brain
2011
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
Ras-dependent Mitogen-activated Protein Kinase Activation by G Protein-coupled Receptors
1997 StandoutNobel
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Thymic pathologies in myasthenia gravis: a preoperative assessment of CAT scan and nuclear based imaging
2016
Reversibility of Joint Thickening in Acromegalic Patients: An Ultrasonography Study
1998
Long-term potentiation in the hippocampus is blocked by tyrosine kinase inhibitors
1991 StandoutNatureNobel
Mechanisms of Antineoplastic Action of Somatostatin Analogs
1998 Nobel
Photodynamic therapy of cancer: An update
2011 Standout
Gastric cancer
2020 Standout
Neuroblastoma
2007 Standout
Comparison of Somatostatin Analog and Meta-Iodobenzylguanidine Radionuclides in the Diagnosis and Localization of Advanced Neuroendocrine Tumors
2001
Serotonin 5-HT1A Receptor-mediated Erk Activation Requires Calcium/Calmodulin-dependent Receptor Endocytosis
1999 StandoutNobel
Incidentally Discovered Adrenal Masses*
1995
Current Approaches and Recommended Algorithm for the Diagnostic Localization of Pheochromocytoma
2004
THE HEAT-SHOCK PROTEINS
1988 Standout
Do Liposomal Apoptotic Enhancers Increase Tumor Coagulation and End-Point Survival in Percutaneous Radiofrequency Ablation of Tumors in a Rat Tumor Model?
2010
PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial
2007
Multi-Modality Therapeutics with Potent Anti-Tumor Effects: Photochemical Internalization Enhances Delivery of the Fusion Toxin scFvMEL/rGel
2009
Medical therapy for clinically non-functioning pituitary adenomas
2008
Phosphorylation of steroid receptors
1989
Gallium-67 scintigraphy: a cornerstone in functional imaging of lymphoma
2003
Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation
2017 StandoutNobel
Uterine Estrogen Receptorin Vivo: Phosphorylation of Nuclear Specific Forms on Serine Residues
1991
Radiomics: Extracting more information from medical images using advanced feature analysis
2012 Standout
Gender- and age-related differences in the endocrine parameters of acromegaly
2002
Steroid Receptor Family: Structure and Functions
1990
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017
Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay
2005 Standout
Imaging and cancer: A review
2008
Gene regulation by steroid hormones
1989 Standout
Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides
2008
The Human Cancer Antigen Mesothelin Is More Efficiently Presented to the Mouse Immune System when Targeted to the DEC‐205/CD205 Receptor on Dendritic Cells
2009 StandoutNobel
Tensor Regression with Applications in Neuroimaging Data Analysis
2013 Standout
Inflammatory abdominal aortic aneurysms: A thirty-year review
1985
111In-DOTA-lanreotide scintigraphy in patients with tumors of the lung.
2001
Management of Graves’ Ophthalmopathy: Reality and Perspectives*
2000
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
2013 StandoutNobel
Extinction of the tumor necrosis factor locus, and of genes encoding the lipopolysaccharide signaling pathway.
1993 StandoutNobel
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Growth Hormone Receptor Antagonists: Discovery, Development, and Use in Patients with Acromegaly
2002
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Impact of Patient’s Age and Disease Duration on Cardiac Performance in Acromegaly: A Radionuclide Angiography Study
1999
Impact of Treating Acromegaly First with Surgery or Somatostatin Analogs on Cardiomyopathy
2008
Calmodulin-stimulated phosphorylation of 17 beta-estradiol receptor on tyrosine.
1984
Nuclear estrogen receptor molecular heterogeneity in the mouse uterus.
1988
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
1998 StandoutScience
Correlation of Early Metastatic Response by123I-Metaiodobenzylguanidine Scintigraphy With Overall Response and Event-Free Survival in Stage IV Neuroblastoma
2003
Oestradiol stimulates tyrosine phosphorylation and hormone binding activity of its own receptor in a cell-free system.
1987
In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients
1997
Approach to the Patient with Persistent Acromegaly after Pituitary Surgery
2010
Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A
1986 StandoutNature
Alpha-folate receptor expression in epithelial ovarian carcinoma and non-neoplastic ovarian tissue.
2009
Cloning of a novel receptor expressed in rat prostate and ovary.
1996 Standout
67Ga scintigraphy in B-cell non-Hodgkin's lymphoma: correlation of 67Ga uptake with histology and transferrin receptor expression.
1999
The Diagnosis and Medical Management of Advanced Neuroendocrine Tumors
2004
Mechanisms of Estrogen Action
2001 Standout
Calcium Rises Abruptly and Briefly Throughout the Cell at the Onset of Anaphase
1986 StandoutScienceNobel
Analysis of transcription and estrogen insensitivity in the female mouse after targeted disruption of the estrogen receptor gene.
1995 StandoutNobel
Polypeptide components of two 8 S forms of chicken oviduct progesterone receptor.
1984
Detection of neuroendocrine tumors: 99mTc-P829 scintigraphy compared with 111In-pentetreotide scintigraphy.
2002
[54] Calmodulin-stimulated estradiol receptor-tyrosine kinase I
1987
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
2016 Standout
Estradiol receptor: phosphorylation on tyrosine in uterus and interaction with anti-phosphotyrosine antibody.
1986
Impact of Metaiodobenzylguanidine Scintigraphy on Assessing Response of High-Risk Neuroblastoma to Dose-Intensive Induction Chemotherapy
2003
Benign and Malignant Pheochromocytoma
1998
Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase
1995 StandoutScience
Calcium calmodulin-dependent microtubule-associated protein 2 kinase: broad substrate specificity and multifunctional potential in diverse tissues
1985
A Protein Kinase Inhibitor Gene Reduces Both Basal and Multihormone-stimulated Prolactin Gene Transcription
1989
Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities.
1995 Standout
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
2009 StandoutScience
Electrochemotherapy as a New Modality in Interventional Oncology: A Review
2018

Works of Secondo Lastoria being referenced

Immunohistochemical reactivity of anti-melanoma monoclonal antibody 225.28S in human breast cancer biopsies.
2001
Successful Treatment of a Patient with a Thymoma and Pure Red-Cell Aplasia with Octreotide and Prednisone
1997
Early radiological assessment of locally advanced pancreatic cancer treated with electrochemotherapy
2017
Iodine-131 metaiodobenzylguanidine scintigraphy for localization of lesions in children with neuroblastoma: comparison with computed tomography and ultrasonography
1993
Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanoma
2013
The pituitary uptake of 111In-DTPA-D-Phe1-octreotide in the normal pituitary and in pituitary adenomas
1999
Preoperative weekly cisplatin–epirubicin–paclitaxel with G-CSF support in triple-negative large operable breast cancer
2009
Orbital Scintigraphy with [111In-Diethylenetriamine Pentaacetic Acid-D-Phe1]-Octreotide Predicts the Clinical Response to Corticosteroid Therapy in Patients with Graves’ Ophthalmopathy
1998
The role of radiolabeled somatostatin analogs in adrenal imaging
1996
Hormone levels and tumour size response to quinagolide and cabergoline in patients with prolactin‐secreting and clinically non‐functioning pituitary adenomas: predictive value of pituitary scintigraphy with 123I‐methoxybenzamide
2000
18F-FDG positron autoradiography with a particle counting silicon pixel detector
2008
Diagnosis of ovarian cancer with radiolabelled monoclonal antibodies: Our experience using 131I—B72.3
1989
Correlation of Scintigraphic Results Using123I-Methoxybenzamide with Hormone Levels and Tumor Size Response to Quinagolide in Patients with Pituitary Adenomas
1998
The role of gallium-67 tumour scintigraphy in patients with small, non-cleaved cell lymphoma
1993
Electrochemotherapy in locally advanced pancreatic cancer: Preliminary results
2015
Phosphorylation of calf uterus 17β-estradiol receptor by endogenous Ca2+-stimulated kinase activating the hormone binding of the receptor
1982
Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease.
2006
Evidence that invivo estradiol receptor translocated into nuclei is dephosphorylated and released into cytoplasm
1982
Detecting deep venous thrombosis with technetium-99m-labeled synthetic peptide P280.
1995
The Diagnosis of Nonfunctioning Pheochromocytoma The Role of I-123 MIBG Imaging
1995
ATP-dependent enzyme activating hormone binding of estradiol receptor
1981
90Yttrium-Ibritumomab-Tiuxetan as First-Line Treatment for Follicular Lymphoma: 30 Months of Follow-Up Data From an International Multicenter Phase II Clinical Trial
2012
18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer.
2006
Somatostatin receptor subtype specificity and in vivo binding of a novel tumor tracer, 99mTc-P829.
1998
In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phe1-octreotide scintigraphy.
1998
Local concentration of folate binding protein GP38 in sections of human ovarian carcinoma by in vitro quantitative autoradiography.
1996
Inflammatory aneurysm of the abdominal aorta with coronary arteritis.
1981
Prediction of efficacy of octreotide therapy in patients with acromegaly.
1996
Feasibility and Safety of Intraoperative Electrochemotherapy in Locally Advanced Pancreatic Tumor: A Preliminary Experience
2014
In vitro and in vivo expression of somatostatin receptors in intermediate and malignant soft tissue tumors.
2003
AIDS and nuclear medicine.
1995
Direct evidence of in vitro phosphorylation-dephosphorylation of the estradiol-17β receptor. role of Ca2+-Calmodulin in the activation of hormone binding sites
1984
Rankless by CCL
2026